1. Home
  2. AIFA vs SCLX Comparison

AIFA vs SCLX Comparison

Compare AIFA & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo All In FutureTech Alliance Inc. Common Stock

AIFA

All In FutureTech Alliance Inc. Common Stock

BUY

Current Price

$4.00

Market Cap

27.2M

ML Signal

BUY

Logo Scilex Holding Company

SCLX

Scilex Holding Company

BUY

Current Price

$2.54

Market Cap

27.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AIFA
SCLX
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2M
27.9M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
AIFA
SCLX
Price
$4.00
$2.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 387.2K
38.6K
Earning Date
11-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$7,655,039.00
★ $30,253,000.00
Revenue This Year
N/A
$118.16
Revenue Next Year
N/A
$186.31
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 20.50
N/A
52 Week Low
$1.52
$2.52
52 Week High
$8.93
$27.00

Technical Indicators

Market Signals
Indicator
AIFA
SCLX
Relative Strength Index (RSI) 45.06 17.44
Support Level $2.80 N/A
Resistance Level $8.93 $7.77
Average True Range (ATR) 0.78 0.35
MACD -0.28 -0.06
Stochastic Oscillator 4.96 0.93

Price Performance

Historical Comparison
AIFA
SCLX

About AIFA All In FutureTech Alliance Inc. Common Stock

All In FutureTech Alliance Inc operates an AI-focused digital infrastructure platform. Its activities include opportunities in AI infrastructure, silicon photonics-enabled computing, fiber-optic network transmission, digital infrastructure services, and technology-related initiatives. The company is also developing the AIFA platform, which is intended to combine AI computing capacity, fiber-optic network infrastructure, AI education, and AI-related applications.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: